The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Psychiatry. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice. https://www.nejm.org/action/showPodcastsFeeds NEJM Group Sat, 10 Oct 2026 23:24:34 GMT 2026 NEJM Group en-us 1440 Older adults are vulnerable to firearm-related harms. Medicare’s annual wellness visit presents an opportunity to engage older adults and their families or caregivers in conversations about firearms. https://www.nejm.org/doi/full/10.1056/NEJMp2608481?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2608481 Lena K. Makaroun, Timothy W. Farrell, Marian E. Betz 2026-10-10 Firearm-Related Discussions as an Age-Friendly Intervention When public health measures conflict with cultural, relational, and emotional practices surrounding severe illness and death, they may lead to uprisings that increase the risk of infection spread. https://www.nejm.org/doi/full/10.1056/NEJMp2608136?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2608136 Celestin Mutuyimana, Clare Killikelly 2026-10-08 Grief as a Vector for Disease — Tradition and Public Health in Ebola Outbreaks The efficacy and popularity of GLP-1 agents have sparked a race to develop increasingly potent therapies. But protections for people enrolled in trials of investigational products may be inadequate. https://www.nejm.org/doi/full/10.1056/NEJMp2609407?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2609407 Sarah H. Schmitz 2026-10-08 Beyond Percentage of Weight Lost — Protecting Participants in Obesity Trials Prediction-market platforms are introducing betting on clinical trials. Although these markets could produce useful signals about the likelihood of a trial’s success, they could also compromise trial integrity. https://www.nejm.org/doi/full/10.1056/NEJMp2610547?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2610547 Matthew Vogel, Rona Yaeger, Olivier J. Wouters 2026-10-07 Clinical Trial Prediction Markets — Information, at What Cost? Recently launched smart vaping devices provide financial incentives tethered to use or engagement metrics. The addictive potential of such devices poses public health concerns. https://www.nejm.org/doi/full/10.1056/NEJMp2606580?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2606580 Amanda M. Palmer, Tracy T. Smith, Benjamin A. Toll 2026-10-01 Vaping for Crypto — Smart Devices, Risky Business This Double Take video describes the burden of global tobacco use and examines evidence-based tobacco-cessation strategies, including their implementation and associated challenges in India and Vietnam. https://www.nejm.org/doi/full/10.1056/NEJMp2414537?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2414537 Pratima Murthy, Hoang Van Minh, Donna Shelley, Nancy A. Rigotti, Kamran Siddiqi, Emily Ling, Darren Taichman 2026-10-01 Double Take: Tobacco-Cessation Treatment for Global Impact When a robust long-time patient with chronic pain and heavy alcohol use declines precipitously after a complicated hospital course, her medical team must find a way to revive her old self. https://www.nejm.org/doi/full/10.1056/NEJMp2603393?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2603393 Michael A. Incze, Laura Stolebarger 2026-10-01 The Mayor Settlements of lawsuits against opioid manufacturers and other entities will shape drug policy for decades. Attention is needed to ensure that the funds will be dedicated to evidence-based activities. https://www.nejm.org/doi/full/10.1056/NEJMp2608276?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2608276 Benjamin D. Scher, Heather H. Howard 2026-10-01 Opioid-Settlement Funds — Lessons from Tobacco A 23-year-old man was brought to the ED after intentional ingestion of 2000 mg of sertraline. Six hours after ingestion, spontaneous and sustained, inducible clonus and patellar hyperreflexia were noted in his legs (shown in a video). https://www.nejm.org/doi/full/10.1056/NEJMicm2607537?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMicm2607537 Hiro Takefuji, Junpei Komagamine 2026-10-01 Serotonin Syndrome To address drivers of poor child health, society should move from responding to health crises one symptom and one child at a time to reimagining ecosystems in ways that facilitate healthy development. https://www.nejm.org/doi/full/10.1056/NEJMp2609124?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2609124 Christopher B. Forrest, Neal Halfon 2026-09-24 Declining Child Health in the United States — Addressing the Developmental Ecosystem How can anyone in the U.S. medical community help children facing down the demons unleashed on them by the human traffickers entrusted with delivering them to better lives? https://www.nejm.org/doi/full/10.1056/NEJMp2601340?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2601340 Brandon Oddo 2026-09-24 Gaps and Borders For more than 25 years, narcolepsy type 1 (formerly narcolepsy with cataplexy) has been known to be associated with a deficiency of orexin within cerebrospinal fluid (CSF) and reduced staining of orexin-containing hypothalamic neurons on autopsy.1 Subsequent work has led to the current understanding of narcolepsy type 1... https://www.nejm.org/doi/full/10.1056/NEJMe2607491?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMe2607491 Lynn Marie Trotti 2026-09-24 Targeted Treatment for Narcolepsy Type 1 Drs. Yanagisawa and Mignot received the 2026 Albert Lasker Award for Basic Medical Research for their pivotal work in the discovery of the orexin (hypocretin) system and its role in narcolepsy. https://www.nejm.org/doi/full/10.1056/NEJMcibr2608811?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMcibr2608811 Sebastiaan Overeem, Birgitte R. Kornum 2026-09-24 The Legacy of Orexin (Hypocretin) Research in Narcolepsy and Beyond Policymakers have so far failed to hold perpetrators in Jeffrey Epstein’s trafficking network accountable, but the medical and public health community should confront the resulting health crisis. https://www.nejm.org/doi/full/10.1056/NEJMp2605483?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2605483 Nicholas Peoples, Preeti Panda, Hanni Stoklosa 2026-09-17 The Epstein Files Transparency Act and the Health of Trafficked Children A 62-year-old woman with a history of stroke and metastatic breast cancer that was being treated with immunomodulator therapy presented with memory loss, confabulation, anhedonia, ataxia, and weight loss. A diagnosis was made. https://www.nejm.org/doi/full/10.1056/NEJMcpc2603180?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMcpc2603180 Sejal B. Shah, Robert H. Unger, Emily M. Sorg 2026-09-17 Case 26-2026: A 62-Year-Old Woman with Memory Loss, Anhedonia, and Temporal Wasting During Operation Metro Surge in Minneapolis, volunteer health care professionals quickly improvised a new system, often without institutional authorization, to continue to care for terrified patients. https://www.nejm.org/doi/full/10.1056/NEJMp2607981?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2607981 Munira Maalimisaq, Jennifer Needle-Suarez 2026-09-10 When Fear Became the Barrier to Care — Lessons of a Clinical Rapid Response during Operation Metro Surge A dying patient in a state psychiatric hospital has no access to a DNR order that would make the process as peaceful as possible — as the notorious Bedlam casts a shadow over mental health care to this day. https://www.nejm.org/doi/full/10.1056/NEJMp2600529?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMp2600529 Richard Elledge 2026-09-10 The Long Shadow of Bedlam In light of the potential promise of new psychedelic treatments for mental health conditions, the authors present updated FDA guidance for psychedelic drug development, including expedited programs and regulatory flexibility. https://www.nejm.org/doi/full/10.1056/NEJMsb2609286?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMsb2609286 Michael Davis, Tiffany R. Farchione, Bernard A. Fischer, Teresa Buracchio 2026-09-10 FDA’s New Framework for Psychedelic Drugs This review summarizes tobacco-cessation strategies in low- and middle-income countries, with emphasis on population-level interventions, subsidized pharmacotherapy, and systemwide integration to expand access to treatment. https://www.nejm.org/doi/full/10.1056/NEJMra2507061?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMra2507061 Donna Shelley, Nancy A. Rigotti, Pratima Murthy, Hoang Van Minh, Kamran Siddiqi 2026-08-13 Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries A 28-year-old woman presented to the emergency department because of abdominal pain, nausea, vomiting, and dizziness. The body-mass index was 18, and the anion gap was elevated. A diagnosis was made. https://www.nejm.org/doi/full/10.1056/NEJMcpc2603175?rss=searchAndBrowse https://www.nejm.org/doi/full/10.1056/NEJMcpc2603175 Hilarie H. Cranmer, Timothy B. Erickson, Scott R. Beach, Kendra E. Wulczyn 2026-08-13 Case 23-2026: A 28-Year-Old Woman with Nausea, Dizziness, and Metabolic Acidosis